NCT00932867已完成不适用
Surveillance of Efficacy and Safety of Drug PRITOR in patieNts With Arterial Hypertension, Who do Not Tolerate ACE inhibitoR Treatment
适应症
干预措施
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- Bayer
- 入组人数
- 3,114
- 主要终点
- To evaluate efficacy and safety of telmisartan in patients with arterial hypertension, who do not tolerate ACEI treatment
研究概览
简要总结
Surveillance of efficacy and safety of drug PRITOR in patieNts with arterial hypertension, who do not tolerate ACE inhibitoR treatment
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients over 18 years of age
- •Arterial hypertension (SBP < 160 mmHg and DBP < 100 mmHg)
- •Patients, who do not tolerate ACE inhibitors (must be documented in the official ambulant documentation)
- •Inclusion criteria for the control arm (treated by ACEi):
- •Patients over 18 years of age
- •Arterial hypertension (SBP < 160 mmHg and DBP < 100 mmHg)
- •Patients, who tolerate ACEi treatment
排除标准
- •Cholestasis, severe hepatic insufficiency
- •Allergy to telmisartan
- •Gravidity or lactation
- •Exclusion criteria for the arm of patient treated by ACEi:
- •Cholestasis, severe hepatic insufficiency
- •Allergy to ACEi
- •Gravidity or lactation
研究组 & 干预措施
Group 1
干预措施: Kinzal/Pritor (Telmisartan, BAY68-9291) (Drug)
结局指标
主要结局
To evaluate efficacy and safety of telmisartan in patients with arterial hypertension, who do not tolerate ACEI treatment
时间窗: 1 year
次要结局
未报告次要终点
研究者
相似试验
已完成
不适用
A Real-world Study of the Safety of Hypertension Medication Therapy in Japanese Patients With Naïve HypertensionHypertensionNCT06683768Novartis Pharmaceuticals40,563
已完成
不适用
Measuring Adherence to Control HypertensionHypertensionNCT01257347Columbia University124
已完成
Unknown
Evaluation of controlling high blood pressure using a combined amlodipine and perindopril arginine approach in MoroccoHypertensionISRCTN18135766SERVIER (Morocco)1,614
尚未招募
Unknown
Effectiveness of hypertensive drugs for the treatment of bipolar disorderBipolar disorderJPRN-UMIN000054174Juntendo University50,000
招募中
3 期
Patient-driven Management of BP in CKDChronic Kidney DiseaseNCT05546099VA Office of Research and Development160
